| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroprotective Agents | 19 | 2018 | 960 | 3.840 |
Why?
|
| Amyotrophic Lateral Sclerosis | 15 | 2017 | 1472 | 2.590 |
Why?
|
| Hypoxia-Ischemia, Brain | 6 | 2017 | 359 | 1.900 |
Why?
|
| Melatonin | 6 | 2018 | 669 | 1.600 |
Why?
|
| Spinal Cord | 8 | 2015 | 1814 | 1.520 |
Why?
|
| Serotonin | 4 | 2018 | 1047 | 1.400 |
Why?
|
| Receptor, Melatonin, MT1 | 4 | 2018 | 31 | 1.150 |
Why?
|
| Apoptosis | 25 | 2018 | 9526 | 0.970 |
Why?
|
| Methazolamide | 3 | 2016 | 9 | 0.970 |
Why?
|
| Frizzled Receptors | 3 | 2014 | 91 | 0.950 |
Why?
|
| Wnt Proteins | 3 | 2013 | 724 | 0.940 |
Why?
|
| SOX9 Transcription Factor | 4 | 2018 | 146 | 0.940 |
Why?
|
| Cell Death | 14 | 2015 | 1684 | 0.910 |
Why?
|
| Cytochromes c | 7 | 2015 | 173 | 0.890 |
Why?
|
| Tryptophan | 2 | 2015 | 483 | 0.850 |
Why?
|
| Superoxide Dismutase | 8 | 2015 | 596 | 0.850 |
Why?
|
| Mitochondria | 13 | 2015 | 3672 | 0.820 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2017 | 507 | 0.770 |
Why?
|
| Huntington Disease | 5 | 2011 | 1145 | 0.730 |
Why?
|
| HMGB1 Protein | 2 | 2014 | 141 | 0.700 |
Why?
|
| Brain Ischemia | 7 | 2018 | 3038 | 0.650 |
Why?
|
| Neurons | 14 | 2017 | 9504 | 0.630 |
Why?
|
| Neural Stem Cells | 3 | 2017 | 892 | 0.630 |
Why?
|
| MicroRNAs | 5 | 2018 | 3806 | 0.620 |
Why?
|
| Caspase 1 | 4 | 2009 | 227 | 0.620 |
Why?
|
| Infarction, Middle Cerebral Artery | 4 | 2017 | 488 | 0.620 |
Why?
|
| Caspases | 10 | 2015 | 884 | 0.610 |
Why?
|
| Astrocytes | 5 | 2017 | 1354 | 0.600 |
Why?
|
| Cytoprotection | 2 | 2014 | 201 | 0.550 |
Why?
|
| Wnt1 Protein | 2 | 2014 | 123 | 0.530 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2 | 2006 | 44 | 0.530 |
Why?
|
| Caspase 3 | 8 | 2016 | 732 | 0.530 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2016 | 122 | 0.520 |
Why?
|
| Hydrogen Peroxide | 3 | 2014 | 742 | 0.520 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2017 | 286 | 0.520 |
Why?
|
| Disease Models, Animal | 21 | 2017 | 18390 | 0.510 |
Why?
|
| Motor Neurons | 3 | 2015 | 872 | 0.500 |
Why?
|
| Pemphigus | 3 | 2006 | 108 | 0.480 |
Why?
|
| Brain Edema | 2 | 2016 | 608 | 0.480 |
Why?
|
| Substantia Nigra | 1 | 2016 | 348 | 0.470 |
Why?
|
| Hemin | 1 | 2014 | 51 | 0.460 |
Why?
|
| Cerebellar Nuclei | 1 | 2014 | 54 | 0.460 |
Why?
|
| Brain Injuries | 2 | 2018 | 2060 | 0.450 |
Why?
|
| Animals | 55 | 2019 | 169424 | 0.440 |
Why?
|
| Mice, Transgenic | 12 | 2017 | 9558 | 0.430 |
Why?
|
| Globins | 1 | 2014 | 405 | 0.430 |
Why?
|
| Nerve Tissue Proteins | 6 | 2017 | 4417 | 0.430 |
Why?
|
| Keratinocytes | 4 | 2004 | 879 | 0.400 |
Why?
|
| Oxidative Stress | 5 | 2018 | 3145 | 0.390 |
Why?
|
| Carbonic Anhydrase Inhibitors | 2 | 2009 | 91 | 0.390 |
Why?
|
| Muscular Atrophy | 1 | 2014 | 335 | 0.380 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2014 | 305 | 0.380 |
Why?
|
| Antioxidants | 5 | 2013 | 1678 | 0.370 |
Why?
|
| Mice | 33 | 2019 | 82051 | 0.360 |
Why?
|
| Central Nervous System Agents | 1 | 2011 | 74 | 0.360 |
Why?
|
| Parkinsonian Disorders | 1 | 2013 | 285 | 0.350 |
Why?
|
| Autophagy | 3 | 2017 | 1349 | 0.350 |
Why?
|
| Drug Design | 1 | 2015 | 1050 | 0.350 |
Why?
|
| Neuroglia | 2 | 2015 | 961 | 0.340 |
Why?
|
| Liver Diseases | 1 | 2018 | 1307 | 0.340 |
Why?
|
| Stroke | 5 | 2018 | 9790 | 0.340 |
Why?
|
| Blotting, Western | 9 | 2019 | 5042 | 0.340 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 770 | 0.320 |
Why?
|
| Membrane Potential, Mitochondrial | 5 | 2014 | 297 | 0.320 |
Why?
|
| Reperfusion Injury | 2 | 2013 | 1034 | 0.320 |
Why?
|
| Osteoporosis | 1 | 2018 | 1606 | 0.320 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2016 | 1041 | 0.310 |
Why?
|
| Gene Expression Regulation | 6 | 2017 | 11928 | 0.310 |
Why?
|
| Cells, Cultured | 12 | 2017 | 19035 | 0.300 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2009 | 115 | 0.300 |
Why?
|
| Acantholysis | 2 | 2006 | 11 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2019 | 8201 | 0.300 |
Why?
|
| Stem Cell Transplantation | 2 | 2017 | 1602 | 0.300 |
Why?
|
| Neurogenesis | 1 | 2014 | 866 | 0.290 |
Why?
|
| Hypothermia, Induced | 1 | 2012 | 756 | 0.290 |
Why?
|
| Autoantibodies | 3 | 2006 | 2131 | 0.280 |
Why?
|
| Corpus Striatum | 1 | 2013 | 1238 | 0.280 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 1489 | 0.280 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 1249 | 0.280 |
Why?
|
| Cell Proliferation | 7 | 2018 | 10490 | 0.280 |
Why?
|
| beta Catenin | 1 | 2012 | 1048 | 0.270 |
Why?
|
| Stem Cells | 4 | 2017 | 3538 | 0.270 |
Why?
|
| Neural Tube Defects | 1 | 2009 | 255 | 0.270 |
Why?
|
| Enzyme Activation | 8 | 2014 | 3594 | 0.270 |
Why?
|
| Ribosomal Proteins | 1 | 2009 | 371 | 0.270 |
Why?
|
| Signal Transduction | 13 | 2019 | 23639 | 0.270 |
Why?
|
| Neurodegenerative Diseases | 4 | 2011 | 1095 | 0.270 |
Why?
|
| Caspase 9 | 4 | 2014 | 185 | 0.260 |
Why?
|
| Chloride Channels | 2 | 2019 | 222 | 0.260 |
Why?
|
| Cognition Disorders | 2 | 2019 | 3984 | 0.260 |
Why?
|
| Deep Brain Stimulation | 1 | 2014 | 847 | 0.250 |
Why?
|
| Ischemia | 1 | 2014 | 1900 | 0.250 |
Why?
|
| Oxidopamine | 2 | 2016 | 173 | 0.240 |
Why?
|
| Carrier Proteins | 5 | 2008 | 4948 | 0.240 |
Why?
|
| Receptor, Melatonin, MT2 | 2 | 2018 | 82 | 0.240 |
Why?
|
| Immunohistochemistry | 9 | 2019 | 11139 | 0.240 |
Why?
|
| Receptors, Neurokinin-1 | 2 | 2015 | 134 | 0.240 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1660 | 0.240 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2016 | 370 | 0.220 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2015 | 1339 | 0.220 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2013 | 616 | 0.220 |
Why?
|
| Sleep | 1 | 2018 | 4796 | 0.200 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 2150 | 0.200 |
Why?
|
| Glioma | 4 | 2018 | 3523 | 0.200 |
Why?
|
| Minocycline | 1 | 2003 | 170 | 0.200 |
Why?
|
| Epidermis | 2 | 2004 | 539 | 0.190 |
Why?
|
| Cell Survival | 4 | 2016 | 5800 | 0.190 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 3408 | 0.190 |
Why?
|
| Bromodeoxyuridine | 3 | 2017 | 310 | 0.180 |
Why?
|
| Endoplasmic Reticulum | 2 | 2006 | 1129 | 0.180 |
Why?
|
| Transfection | 5 | 2016 | 5767 | 0.180 |
Why?
|
| Membrane Potentials | 2 | 2017 | 1090 | 0.180 |
Why?
|
| Blood-Brain Barrier | 2 | 2017 | 1034 | 0.180 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2001 | 200 | 0.170 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2016 | 1078 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 18047 | 0.160 |
Why?
|
| Down-Regulation | 3 | 2017 | 2942 | 0.160 |
Why?
|
| Receptors, Melatonin | 1 | 2018 | 31 | 0.160 |
Why?
|
| Hippocampus | 3 | 2017 | 3783 | 0.160 |
Why?
|
| Brain | 5 | 2014 | 27439 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 7 | 2017 | 22365 | 0.150 |
Why?
|
| Rats | 7 | 2017 | 23839 | 0.150 |
Why?
|
| Membrane Transport Modulators | 1 | 2017 | 24 | 0.150 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 3 | 2006 | 32 | 0.150 |
Why?
|
| Cell Differentiation | 4 | 2017 | 11674 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2017 | 66 | 0.150 |
Why?
|
| Nortriptyline | 2 | 2008 | 79 | 0.140 |
Why?
|
| Liver | 1 | 2013 | 7575 | 0.140 |
Why?
|
| Hexokinase | 1 | 2017 | 124 | 0.140 |
Why?
|
| Dynamins | 1 | 2017 | 141 | 0.140 |
Why?
|
| Cerebral Cortex | 6 | 2017 | 5827 | 0.140 |
Why?
|
| Sympatholytics | 1 | 2016 | 82 | 0.140 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5808 | 0.140 |
Why?
|
| Apoptosis Inducing Factor | 2 | 2014 | 51 | 0.130 |
Why?
|
| Interleukin-1beta | 2 | 2015 | 1021 | 0.130 |
Why?
|
| Time Factors | 8 | 2014 | 40271 | 0.130 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 3 | 2006 | 146 | 0.130 |
Why?
|
| Pyramidal Cells | 1 | 2019 | 367 | 0.130 |
Why?
|
| Cell Line | 6 | 2019 | 15610 | 0.130 |
Why?
|
| Dendrites | 1 | 2019 | 471 | 0.130 |
Why?
|
| Brain Neoplasms | 4 | 2018 | 9177 | 0.130 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 3710 | 0.130 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 3436 | 0.130 |
Why?
|
| Up-Regulation | 3 | 2014 | 4132 | 0.120 |
Why?
|
| Hybrid Cells | 1 | 2015 | 421 | 0.120 |
Why?
|
| Enkephalin, Leucine | 1 | 2014 | 16 | 0.120 |
Why?
|
| Angiopoietin-1 | 1 | 2015 | 123 | 0.120 |
Why?
|
| Dacarbazine | 1 | 2018 | 560 | 0.120 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2014 | 59 | 0.120 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2014 | 43 | 0.120 |
Why?
|
| HeLa Cells | 3 | 2006 | 3091 | 0.120 |
Why?
|
| Neurotensin | 1 | 2014 | 60 | 0.120 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 261 | 0.120 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 560 | 0.120 |
Why?
|
| Stereoisomerism | 1 | 2015 | 612 | 0.120 |
Why?
|
| Posterior Horn Cells | 1 | 2014 | 87 | 0.120 |
Why?
|
| Humans | 38 | 2018 | 768369 | 0.110 |
Why?
|
| Substance P | 1 | 2015 | 334 | 0.110 |
Why?
|
| Vasospasm, Intracranial | 1 | 2016 | 215 | 0.110 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 435 | 0.110 |
Why?
|
| RNA, Messenger | 4 | 2016 | 12813 | 0.110 |
Why?
|
| Lateral Ventricles | 1 | 2014 | 145 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2014 | 163 | 0.110 |
Why?
|
| Malondialdehyde | 1 | 2013 | 113 | 0.110 |
Why?
|
| Male | 25 | 2019 | 364761 | 0.110 |
Why?
|
| Riluzole | 1 | 2013 | 61 | 0.110 |
Why?
|
| Hep G2 Cells | 1 | 2014 | 379 | 0.110 |
Why?
|
| Medulla Oblongata | 1 | 2014 | 248 | 0.110 |
Why?
|
| Neuronavigation | 1 | 2014 | 169 | 0.110 |
Why?
|
| Subcellular Fractions | 1 | 2014 | 527 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 1892 | 0.110 |
Why?
|
| Gene Expression Profiling | 3 | 2013 | 9508 | 0.110 |
Why?
|
| Prediabetic State | 1 | 2019 | 548 | 0.100 |
Why?
|
| Biological Assay | 1 | 2016 | 629 | 0.100 |
Why?
|
| Nerve Fibers | 1 | 2016 | 708 | 0.100 |
Why?
|
| DNA Fragmentation | 2 | 2004 | 240 | 0.100 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 1121 | 0.100 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 332 | 0.100 |
Why?
|
| Dipyrone | 1 | 2011 | 9 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2018 | 2604 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2014 | 1147 | 0.100 |
Why?
|
| Permeability | 1 | 2014 | 725 | 0.100 |
Why?
|
| Aspartate Aminotransferases | 1 | 2013 | 414 | 0.100 |
Why?
|
| Mutation | 3 | 2013 | 30235 | 0.100 |
Why?
|
| Postmortem Changes | 1 | 2011 | 119 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2013 | 489 | 0.090 |
Why?
|
| Choline | 1 | 2013 | 518 | 0.090 |
Why?
|
| Creatine | 1 | 2013 | 427 | 0.090 |
Why?
|
| Lentivirus | 1 | 2014 | 519 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 507 | 0.090 |
Why?
|
| Aspartic Acid | 1 | 2013 | 577 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 2003 | 0.090 |
Why?
|
| Oncogenes | 1 | 2016 | 1235 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 432 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4582 | 0.090 |
Why?
|
| Amino Acid Sequence | 3 | 2009 | 13447 | 0.090 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 212 | 0.090 |
Why?
|
| Embryo, Mammalian | 2 | 2017 | 1674 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 3734 | 0.090 |
Why?
|
| Cell Movement | 3 | 2017 | 5223 | 0.090 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2009 | 413 | 0.090 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 1448 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 2003 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2015 | 1322 | 0.090 |
Why?
|
| Cell Line, Transformed | 2 | 2008 | 868 | 0.090 |
Why?
|
| Cyclin D1 | 1 | 2012 | 454 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1143 | 0.080 |
Why?
|
| Regeneration | 1 | 2018 | 1527 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1609 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 1906 | 0.080 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 17637 | 0.080 |
Why?
|
| Valproic Acid | 1 | 2011 | 443 | 0.080 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 3074 | 0.080 |
Why?
|
| Gene Transfer Techniques | 1 | 2014 | 1209 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2003 | 7895 | 0.080 |
Why?
|
| Mesocricetus | 1 | 2009 | 255 | 0.080 |
Why?
|
| Neural Tube | 1 | 2009 | 48 | 0.080 |
Why?
|
| Neurotransmitter Agents | 1 | 2012 | 666 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 8636 | 0.080 |
Why?
|
| Cell Separation | 1 | 2014 | 1725 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 1755 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 2431 | 0.080 |
Why?
|
| Osteosarcoma | 1 | 2014 | 912 | 0.080 |
Why?
|
| Disease Progression | 4 | 2013 | 13643 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2861 | 0.080 |
Why?
|
| Mitochondrial Membranes | 1 | 2009 | 185 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2013 | 6242 | 0.070 |
Why?
|
| Pentachlorophenol | 1 | 2007 | 10 | 0.070 |
Why?
|
| Phenanthrolines | 1 | 2007 | 49 | 0.070 |
Why?
|
| Carotid Artery Diseases | 1 | 2014 | 879 | 0.070 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 12771 | 0.070 |
Why?
|
| Rats, Wistar | 3 | 2019 | 1891 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2016 | 1389 | 0.070 |
Why?
|
| Blotting, Northern | 1 | 2009 | 1553 | 0.070 |
Why?
|
| Maze Learning | 2 | 2019 | 484 | 0.070 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2008 | 186 | 0.070 |
Why?
|
| Caspases, Initiator | 1 | 2006 | 31 | 0.070 |
Why?
|
| Cytotoxins | 1 | 2007 | 154 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 776 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 2072 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2016 | 4022 | 0.060 |
Why?
|
| Meningioma | 1 | 2014 | 1222 | 0.060 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2016 | 1671 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3590 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2009 | 1992 | 0.060 |
Why?
|
| Cricetinae | 1 | 2009 | 2423 | 0.060 |
Why?
|
| Caspase 6 | 2 | 2001 | 15 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3793 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1760 | 0.060 |
Why?
|
| Copper | 1 | 2007 | 368 | 0.060 |
Why?
|
| COS Cells | 1 | 2006 | 1136 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2014 | 3417 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6087 | 0.060 |
Why?
|
| Spinal Cord Injuries | 1 | 2011 | 928 | 0.060 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2004 | 189 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2015 | 26394 | 0.060 |
Why?
|
| Fas Ligand Protein | 1 | 2004 | 218 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 1816 | 0.050 |
Why?
|
| Axons | 1 | 2011 | 1678 | 0.050 |
Why?
|
| RNA Interference | 2 | 2016 | 2832 | 0.050 |
Why?
|
| Receptors, Death Domain | 1 | 2003 | 31 | 0.050 |
Why?
|
| Gene Expression | 2 | 2009 | 7605 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2017 | 14483 | 0.050 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2003 | 88 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 3783 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2012 | 2889 | 0.050 |
Why?
|
| PC12 Cells | 1 | 2003 | 317 | 0.050 |
Why?
|
| Genotype | 1 | 2017 | 13045 | 0.050 |
Why?
|
| Weight Loss | 1 | 2014 | 2710 | 0.050 |
Why?
|
| Female | 14 | 2018 | 396926 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2006 | 1251 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2012 | 3663 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2015 | 10127 | 0.050 |
Why?
|
| Cell Line, Tumor | 5 | 2018 | 17149 | 0.050 |
Why?
|
| Proteins | 2 | 2015 | 6009 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2562 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2017 | 3524 | 0.050 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2001 | 48 | 0.050 |
Why?
|
| Models, Biological | 2 | 2009 | 9505 | 0.050 |
Why?
|
| Motor Activity | 1 | 2011 | 2722 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2279 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2003 | 440 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2017 | 65408 | 0.050 |
Why?
|
| Age Factors | 2 | 2018 | 18477 | 0.040 |
Why?
|
| Longevity | 1 | 2008 | 1078 | 0.040 |
Why?
|
| Complement C5a | 1 | 2000 | 100 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2001 | 816 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2004 | 1409 | 0.040 |
Why?
|
| Glycosylation | 1 | 2003 | 1101 | 0.040 |
Why?
|
| Dimerization | 1 | 2001 | 888 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 2750 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2017 | 3637 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1246 | 0.040 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2019 | 110 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2018 | 12176 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2001 | 1650 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 3813 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2696 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2000 | 551 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 666 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 6537 | 0.030 |
Why?
|
| Nitrobenzoates | 1 | 2016 | 17 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1669 | 0.030 |
Why?
|
| Kinetics | 1 | 2004 | 6347 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 551 | 0.030 |
Why?
|
| Quinazolinones | 1 | 2017 | 222 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2000 | 1266 | 0.030 |
Why?
|
| Phenotype | 1 | 2013 | 16712 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 1977 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2017 | 1770 | 0.030 |
Why?
|
| Vitamin A | 1 | 1998 | 611 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 370 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2007 | 4220 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2015 | 624 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2017 | 916 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2017 | 807 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 3735 | 0.030 |
Why?
|
| Binding Sites | 1 | 2003 | 6029 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3790 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2019 | 6429 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2004 | 2964 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2399 | 0.030 |
Why?
|
| Th1 Cells | 1 | 1998 | 1044 | 0.030 |
Why?
|
| Presynaptic Terminals | 1 | 2014 | 302 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2004 | 4570 | 0.020 |
Why?
|
| Antigens | 1 | 2017 | 1443 | 0.020 |
Why?
|
| Middle Aged | 7 | 2018 | 223406 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 4362 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 3612 | 0.020 |
Why?
|
| Inflammation | 1 | 2011 | 10863 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2017 | 1502 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 2565 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1840 | 0.020 |
Why?
|
| Species Specificity | 1 | 2015 | 2419 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2017 | 2268 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2017 | 3635 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 6241 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2477 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 6135 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2011 | 599 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2014 | 1192 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 8051 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3619 | 0.020 |
Why?
|
| Adult | 5 | 2017 | 223528 | 0.020 |
Why?
|
| Rabbits | 2 | 2006 | 4786 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2009 | 24310 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 1889 | 0.020 |
Why?
|
| Pregnancy | 1 | 2009 | 30179 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 717 | 0.020 |
Why?
|
| Prognosis | 2 | 2018 | 30031 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2011 | 1685 | 0.020 |
Why?
|
| Sepsis | 1 | 2000 | 2602 | 0.020 |
Why?
|
| Risk | 1 | 2018 | 9642 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2882 | 0.020 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2007 | 433 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5893 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 4213 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 796 | 0.010 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2014 | 2427 | 0.010 |
Why?
|
| Sex Factors | 1 | 2018 | 10647 | 0.010 |
Why?
|
| Anxiety | 1 | 2019 | 4655 | 0.010 |
Why?
|
| Cell Count | 1 | 2007 | 1834 | 0.010 |
Why?
|
| Cytokines | 1 | 1998 | 7440 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12096 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5342 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2007 | 1765 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2016 | 6278 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2008 | 979 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12561 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2003 | 661 | 0.010 |
Why?
|
| Aging | 1 | 2000 | 8762 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2000 | 123 | 0.010 |
Why?
|
| Histones | 1 | 2011 | 2596 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 2003 | 0.010 |
Why?
|
| bcl-Associated Death Protein | 1 | 2000 | 102 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 1315 | 0.010 |
Why?
|
| Rats, Long-Evans | 1 | 2000 | 380 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 2011 | 2665 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2007 | 1061 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2000 | 282 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2000 | 575 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2000 | 412 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 36840 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1998 | 359 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 1734 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1998 | 438 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2008 | 2994 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1998 | 826 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 1998 | 375 | 0.010 |
Why?
|
| Oxygen | 1 | 2008 | 4269 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 16023 | 0.010 |
Why?
|
| Glucose | 1 | 2008 | 4355 | 0.010 |
Why?
|
| Organ Size | 1 | 2000 | 2268 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 5793 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 1998 | 964 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2000 | 2232 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1998 | 1207 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2007 | 9379 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2000 | 2491 | 0.010 |
Why?
|
| Cell Division | 1 | 1998 | 4479 | 0.010 |
Why?
|
| Adolescent | 2 | 2014 | 89163 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 74915 | 0.010 |
Why?
|
| Aged | 2 | 2017 | 171514 | 0.000 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2000 | 4534 | 0.000 |
Why?
|
| Young Adult | 1 | 2014 | 60038 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1998 | 5490 | 0.000 |
Why?
|
| Child | 1 | 2014 | 80856 | 0.000 |
Why?
|